Back to list

Garner Health

Doctor-ranking data to cut employer health costs
Uses doctor-performance data to cut employer health costs; raised $100M at a $2.7B valuation in May 2026.
Healthcare
Current Valuation
$2.7B
as of 2026-05
UNICORN

QL Price

$2.7B
0% vs last round
QuantLogix's current estimate for Garner Health, published 2026-08-30 — in line with the last disclosed round of $2.7B (2026-05).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $2.7B 2026-05 weight 0.79
How this price has held up
No round has priced for Garner Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-08-30 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Garner Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Garner Health, 2026-08-30 (af30fbc1dd327e4d). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Garner Health going public?
No. Garner Health is private and has not filed to go public. There is no S-1 on file.
What is Garner Health's valuation in 2026?
Garner Health is valued at $2.7B as of May 2026, set by its Venture ($100M, May 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Garner Health filed an S-1?
No public S-1 is on file for Garner Health.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Last Round
Venture — $100M (May 2026)
IPO Status
Private

Fundraising Status

Venture · $100M · 3 mo ago
Private1 disclosed rounds

Venture Impact

Round Size
$100M
Primary financing announced
Post-Money Valuation
$2.7B
Company-announced mark
Round / Post-Money
3.7%
New capital ÷ post-money
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.

Funding History

RoundAmountDateLead InvestorPost-Money
Venture$100MMay 2026$2.7B

Talent Signal

Hiring data for Garner Health has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
HealthcareData
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-05. Refreshed quarterly.